US$ 26.81
glp 1 agonist vs bariatric surgery Metabolic and versus glucagon-like peptide-1 receptor therapy: A comparison of cardiovascular outcomes in patients with obesity GLP-1s Vs. Bariatric Surgery For
Description
doi: 10.1172/jci200215001

Lack of effect of islet amyloid polypeptide on hepatic glucose output in the in situ-perfused rat liver

27 Effective management combines patient education, gradual dose escalation, and nonpharmacologic strategies

PYY, Peptide YY
